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TO THE EDITOR
Skin is subject to age-associated struc-
tural and functional changes over time.
Clinically, aging skin is characterized
by the appearance of wrinkles, reduced
skin elasticity, and an increased rough-
ness (Kligman, 1989). Approximately
80% of overall aging-associated skin
changes can be attributed to extrinsic
factors such as UV light harming skin
cells in both epidermis and dermis.
Among those inflicted damages are
effects on cellular DNA that are a major
factor in the process of skin aging
(Krutmann, 2001; Berneburg et al.,
2005).
A vitamin that plays a central role in
DNA synthesis and repair is folic acid.
It exists in a number of different forms,
which occur naturally in different food
sources such as dark green leafy vege-
tables, dried beans, and asparagus
(Rampersaud et al., 2003) or as folic
acid, which is the synthetic form of the
vitamin used in supplements.
A large body of evidence indicates
that an adequate folate intake is crucial
for a variety of physiological processes
(Rampersaud et al., 2003), for instance
throughout gestation to guarantee nor-
mal development and growth (Bailey
et al., 2003). Folate was utilized in the
treatment of oral ulcers from metho-
trexate and also to inhibit gingival
hyperplasia from phenytoin use and
pregnancy (Thomas and Pack, 1982;
Barrett, 1986; Drew et al., 1987). On
the other hand, folate deficiency is
associated with chromosomal damage
and gene mutations in lymphocytes and
the hemopoietic system (Blount, 1997;
Fenech et al., 1997). With respect to
normal skin, however, there is only
very little knowledge regarding the role
of folates although there are several
studies on folate status and skin
disease.
We, therefore, hypothesized that
skin cells might benefit from an exo-
genous folic acid supplementation. To
tackle this question experimentally, we
first focused on human dermal fibro-
blasts (HDFs), which play an important
role in connective tissue metabolism.
HDFs were cultured by outgrowth from
skin biopsies obtained from different
donors as described previously (Sta¨b
et al., 2000). All donors provided
written, informed consent. HDFs were
seeded in culture dishes in a density of
1.6104 cells/cm2 using folic acid-free
medium (Biochrom AG, Berlin, Ger-
many). This modified DMEM did not
contain any serum to avoid addition of
undefined amounts of folic acid. HDFs
were cultivated in folic acid-free med-
ium or medium that contained 9.1 mM
(1 ) or 36.4 mM (4 ) folic acid,
respectively. A concentration of 9.1 mM
folic acid corresponds to the folic acid
concentration used in standard culture
media for HDF (Sta¨b et al., 2000). After
preincubation of 52 hours at 371C in an
atmosphere of 7% CO2, cells were
washed with folic acid-free medium
and the medium was changed. After a
postincubation of 2 hours, cell extracts
were prepared from each group. Protein
quantification was performed using the
Experion Pro260 analysis kit and ex-
perion automated electrophoresis sys-
tem (BioRad, Mu¨nchen, Germany) to
allow for standardization of folic acid
concentration relative to protein con-
tent. Quantitative determination of folic
acid was carried out by means of
HPLC–tandem mass spectrometry. For
HPLC: Agilent 1100 series (Agilent
Technologies GmbH, Waldbronn, Ger-
many), separation column: LiChrospher
RP select B, 60 2 mm, 5 mm (Merck,
Darmstadt, Germany). Mobile phase:
gradient: A: 0.25% aqueous acetic acid,
B: acetonitrile: 0 minute: 95% A, 5% B,
2–5 minutes: 60% A, 40% B, 6–10 min-
utes: 100% B, 11–17 minutes: 95% A,
5% B. Flow rate: 300ml/minutes,
injection volume: 5 ml. For mass spec-
trometry: Quattro micro (Micromass-
Waters, Eschborn, Germany), operating
in positive ion mode. The detection was
carried out by ‘‘multireaction monitor-
ing’’ of the transition m/z 442.0
[MþH]þ-m/z 295.0 (quantifier) and
m/z 442.0 [MþH]þ-m/z 312.0 (qua-
lifier). Quantification was carried out
by external standard calibration.
To determine if dermal cells have
the ability to take up folic acid, HDFs
were cultured in folic acid-free medium
or medium that contained 9.1 mM (1 )
or 36.4 mM (4 ) folic acid, respectively.
Individual results are depicted in Figure
1a and statistical significance was con-
firmed by Wilcoxon’s signed rank test
(Pp0.05, n¼ 6). This type of data
presentation clearly shows that six out
of six volunteers display a dose-depen-
dent folic acid uptake, however, with
varying amplitudes. As demonstrated in
Figure 1a, extracts of cultured cells
without folic acid supplementation
showed vitamin concentrations below
the detection limit. Interestingly, folic
acid is dose-dependently taken up by
these cells. For these studies, we used
synthetic folic acid because it is more
easily absorbed than naturally occur-
ring food folates. Specifically, it does
not require intestinal enzymatic clea-
vage before absorption (Rampersaud
et al., 2003) and displays in addition
an enhanced chemical stability.
As folic acid plays a central role in
cellular metabolism, particularly in
DNA repair, we investigated whether
UV irradiation affects folic acid uptake.
HDFs were again cultured in the
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Abbreviations: HDF, human dermal fibroblast; RFC-1, reduced folate carrier-1
absence or presence of increasing
amounts of folic acid and either ex-
posed to UV irradiation or sham-irra-
diated. The effects of UV exposure were
determined by subjecting cells to
135 mJ/cm2 solar-simulated irradiation
and preparing cell extracts after
24 hours. The UV source (UV solar
simulator; Oriel Corporation, Stratford,
CT) was equipped with UV-B and UV-C
safety filters. UV density was deter-
mined using an IL-1700 radiometer
(International Light, Newburyport,
MA). Under all conditions, investigated
cell viability was verified by 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenylte-
trazolium bromide and lactate
dehydrogenase assay.
Figure 1b shows folic acid concen-
tration in HDF with the indicated folic
acid supplementation 24 hours after
exposure (þUV) or nonexposure
(UV) to 135 mJ/cm2 solar-simulated
irradiation (n¼7). Individual results are
depicted and statistical significance
was confirmed by Wilcoxon’s signed
rank test (Pp0.05, seven out of nine
responders). Our data demonstrate that
HDFs increase their intracellular folate
levels when exposed to UV irradiation
provided that sufficient amounts of folic
acid are supplied externally.
Based on these observations we
hypothesized that higher intracellular
folate concentrations as a result of UV
irradiation are paralleled by enhanced
expression of folate carriers. For folates,
several carrier systems have been iden-
tified with the reduced folate carrier-1
(RFC-1) representing the major trans-
port system in mammalian cells and
tissues (Matherly, 2001). This carrier
serves to maintain sufficient levels of
intracellular folates which play a cen-
tral part in one-carbon transfer reac-
tions (Bailey and Gregory, 1999). It is
speculated that a decreased RFC-1
expression in human tissues contributes
to disease states associated with an
inadequate folate status (Whetstine
et al., 2002). Consequently, we isolated
full-thickness human skin biopsies after
acute UV irradiation and investigated
RFC-1 gene expression. Before UV
exposure, the respective individual
minimal erythemal dose, solar-simu-
lated irradiation for each volunteer,
was determined according to the Eur-
opean Cosmetic, Toiletry and Perfum-
ery Industry Guidelines using the SU
5,000 solar sun simulator (m.u.t.
GmbH, Wedel, Germany). After that,
buttock skin was irradiated with an
individual dose of two minimal erythe-
mal dose solar-simulated irradiation
(n¼8, age 26–62 years). Twenty-four
hours after UV exposure, full-thickness
punch biopsies from UV-exposed as
well as UV-protected control areas
were obtained, dermis and epidermis
were separated using dispase digestion
and RFC-1 mRNA was determined by
quantitative reverse transcription–PCR.
Total RNA was isolated as published
(Su¨del et al., 2003). Reverse transcrip-
tion of RNA was performed using the
high capacity cDNA archive kit (Ap-
plied Biosystems, Foster City, CA)
according to the manufacturer’s recom-
mendation. The analysis of mRNA
expression was carried out with the
ABI PRISM sequence detection system
7700 (Parker H. Petit Institute for
Bioengineering and Bioscience, Geor-
gia Institute of Technology, Atlanta,
GA) using TaqMans assay reagents
(Applied Biosystems) containing gene-
specific PCR primers (RFC ordering no.
HS 00953342_m1; batch no. 39347;
Lot-Nr. 393472 925 A04) as well as
FAMTM-labelled probe. For quantifica-
tion, RFC-1 gene expression was nor-
malized to the housekeeping gene 18S
rRNA. The amplification protocol was
as follows: 2 minutes at 501C, 10 min-
utes at 951C, 15 seconds at 951C, and
1 minute at 591C (40 cycles).
Interestingly, compared with control
areas RFC-1 gene expression was sig-
nificantly increased in irradiated skin
(24 hours: 4257116%; 72 hours:
212750% with the control being set
as 100%, clinical study approval num-
ber by the Ethics Committee of the
Medical Association of Hamburg (OB/
IV/02), all donors provided written,
informed consent). Specifically, follow-
ing irradiation, carrier expression was
significantly enhanced in both human
epidermis and dermis with the dermal
compartment (clinical study approved
by the Ethics Committee of the Medical
Association of Hamburg (OB/VI/03), all
donors provided written, informed con-
sent) displaying higher baseline levels
(Figure 1c).
These studies suggest that in both
epidermal and dermal cells folic acid
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Figure 1. Folic acid uptake by cultured HDFs and RFC-1 mRNA regulation after UV exposure.
(a) Dose-dependent uptake of folic acid by cultured HDFs. (b) UV-dependent uptake of folic acid by
cultured HDFs. (c) UV irradiation increases RFC-1 mRNA expression in dermis and epidermis.
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uptake is significantly increased after
UV irradiation. To answer the question
to which extent folic acid is able to
penetrate human skin in vivo, volun-
teers treated one of their forearms in a
home-in-use study with a cream that
contained 0.03% folic acid. The cream
largely resembled commercially avail-
able cosmetic formulations but was
optimized in terms of folic acid stabi-
lity. This cream was applied twice daily
for 4 weeks according to written
instructions. The recommendations of
the current version of the Declaration of
Helsinki Principles and the guideline of
the International Conference on Har-
monization Good Clinical Practice
were observed as applicable to a
nondrug study. All subjects provided
written, informed consent. Folic acid
content was determined in suction
blister fluid isolated from untreated
control areas or areas treated with the
folic acid-containing formulation. To
analyze folic acid concentration, 50 ml
0.25% aqueous ammonia solution was
added to 100ml of suction blister fluid.
After homogenization, soluble proteins
were precipitated with 100ml acetoni-
trile and separated by centrifugation.
Folic acid concentration was analyzed
in the supernatant by means of
HPLC–tandem mass spectrometry as
described above. Results in Figure 2
are depicted as mean7SD (n¼17
females, age 35–56 years). Significant
differences are marked with an asterisk
(* Pp0.05). As normal distribution
could not be assumed (Shapiro–Wilk
test) Blom-transformed ranks of original
data were analyzed by means of analysis
of variance (generalized Tukey test) with
subjects as repeated measures and folic
acid concentration as qualitative factor.
As shown in Figure 2, folic acid
concentration in suction blister fluids
was substantially increased after treat-
ment compared with the untreated
control area. These data demonstrate
that folic acid exhibits physicochemical
properties (e.g., log P¼2.6370.85,
molecular weight¼ 441.4 g) that allow
for penetration through the skin barrier
making this vitamin bioavailable in
human skin.
Folic acid is sensitive to UV irradia-
tion, giving rise to the hypothesis that
skin pigmentation, among other bio-
logical functions, serves to protect folic
acid in skin (Jablonski and Chaplin,
2000). Photolysis of this vitamin gen-
erates molecules such as pterine-
6-carboxylic acid that can exert toxic
effects on cells. For that reason, we
extensively tested specifically formu-
lated folic acid-containing creams for
skin compatibility and (photo-)toxico-
logy. Overall, in our in vitro and in vivo
studies involving more than 600 volun-
teers (i.e., different test areas with test
periods for up to 6 months), not a single
skin incompatibility was detected.
These data clearly show the safety of
topically applied folic acid in the
specific formulation used.
In summary, skin cells increase both
their folic acid uptake and their RFC-1
gene expression in response to UV
exposure. As folic acid levels are
increased in suction blister fluids after
topical application, this approach ap-
pears to be a targeted means to
enhance the cutaneous supply of this
vitamin in human skin. It can be
speculated that the UV exposure-
mediated increase of RFC-1 serves to
ensure sufficient cellular folate supply.
This hypothesis is based on previous
findings that demonstrate both the
induction of RFC-1 expression (Spre-
cher et al., 1998) and the loss of folates
in psoriasis, probably owing to in-
creased utilization of folate by epider-
mal skin cells (Fry et al., 1971; Touraine
et al., 1973). However, future studies
will have to address this issue to further
elucidate the physiological relevance of
our findings.
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TO THE EDITOR
B-cell-attracting chemokine 1/CXCL13
and secondary lymphoid tissue chemo-
kine/CCL21 are constitutively expressed
within secondary lymphoid organs, reg-
ulating homing of lymphocyte and
dendritic cells to these organs (Nagira
et al., 1997, Gunn et al., 1998a; Legler
et al., 1998; Yoshida et al., 1998).
CXCL13 is a ligand for CXCR5 (Dobner
et al., 1992), which is mainly expressed
on B cells (Forster et al., 1994). CXCL13
is expressed by follicular dendritic cells
and other stromal cells located in the B-
cell areas of secondary lymphoid organs
(Gunn et al., 1998a; Ansel et al., 2000).
CCL21 is a ligand for CCR7 (Burgstahler
et al., 1995), which is highly expressed
on naı¨ve T cells and mature dendritic
cells (Sozzani et al., 1998; Yanagihara
et al., 1998; Saeki et al., 1999). CCL21 is
constitutively expressed by stromal cells
within the T-cell zones of secondary
lymphoid organs, endothelial cells of
high endothelial venules (HEVs), and
lymphatic vessels (Gunn et al., 1998b;
Nagira et al., 1998). Recently, several
researchers have recognized that
CXCL13 and CCL21 are also involved
in some human diseases. CXCL13 and
CCL21 expression was shown in lym-
phoid follicle-like structures in salivary
glands of Sjo¨gren syndrome and in-
flamed synovial specimens of rheuma-
toid arthritis (Shi et al., 2001; Manzo
et al., 2005; Barone et al., 2005).
Expression of CXCL13 was also shown
in lymphoproliferative disorders such as
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Figure 1. Ectopic follicular structures of the skin are positive for CXCL13 and CD21.
Immunohistochemistry for formalin-fixed paraffin-embedded sections was performed as described
previously (Barone et al., 2005). Immunohistochemical staining for CXCL13 (AF801, R&D Systems,
Abingdon, UK) of (a) reactive lymph nodes, (b) Kimura’s disease, (c) primary cutaneous follicle center
lymphoma, (d) primary cutaneous diffuse large B-cell lymphoma, and (e) cutaneous T-cell lymphoma.
Positive staining for CD21 (1F8 Dako, Cambridge, UK) in follicular structures of (f) Kimura’s disease.
Bar¼500 mm.
Abbreviation: HEV, high endothelial venule
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